SCHEMBL6399573

SCHEMBL6399573

NC(=O)N1C(=O)C[N]C(=O)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP3A4 P08684 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
PABPC1 P11940 1/20 0.50
BLM P54132 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
SCN4A P35499 1/20 0.41
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
CES1 P23141 3/20 0.38
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968919 0.77 GABRA1 (0.62) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL6404457 0.76 MEN1 (0.50) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL6401843 0.74 NOTUM (0.44) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL6404429 0.73 ALDH1A1 (0.48) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL4869538 0.69 CES1 (0.68) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL6251744 0.68 NOTUM (0.69) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL7818833 0.68 BRPF1 (0.56) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL11622848 0.67 MEN1 (0.56) KDM4EALDH1A1CYP3A4MEN1MAPT
SCHEMBL11115762 0.67 MEN1 (0.56) KDM4EALDH1A1CYP3A4MEN1MAPT
Oxcarbazepine SCHEMBL4655725 0.67 KDM4E (1.00) KDM4EALDH1A1CYP3A4MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 KDM4E 1617/4885ALDH1A1 408/4885CYP3A4 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.